ABSTRACT INTRODUCTION
(BPKIHS), Dharan, Nepal with an aim to explore iodine status, thyroid function and anti-TPO antibody among pregnant women of eastern Nepal. Ninety-two pregnant women in the second and third trimester were enrolled in this study from primary health care center of three districts namely; Sunsari (n=58), Morang (n=13) and Jhapa (n=21), during July 2013 to August 2014. Inclusion criteria were pregnant women in second and third trimester of gestation. Exclusion criteria were pregnant women taking drugs that interfere in thyroid function, those having a current history of iodine supplement, pregnant women with complications and those who do not want to participate in the study. Demographic information was collected from each woman, and urine (10 ml) and blood (2 ml) samples were collected after taking consent from each women. The ethical clearance for the study was provided by Ethical Review Board of BP Koirala Institute of Health Sciences.
Urine and blood samples were transported to the biochemistry laboratory of BPKIHS and maintained at -20C until analysis. Urinary iodine concentration (UIC) was estimated in urine samples using ammonium persulphate digestion method (APDM) in microplate which is based on Sandell-Kolthoff reaction.
12 Blood samples were analyzed for thyroid hormones (free thyroxine (free T4) and thyroid stimulating hormone (TSH)), thyroglobulin and anti-TPO antibody. Measurement of serum free T4, TSH and thyroglobulin was done by ELISA technique using commercial kits from Diametra, and anti TPOantibodies by Is-anti-TPO IgG kits from Diamedix. The reference ranges provided by the kits manufacturer for free T4, TSH, thyroglobulin and anti-TPO antibody were 0.8-2.2 ng/dL, 0.39-6.16 mIU/L,<40.0 ng/mL, and <20 IU/ml for negative, 20-29.9 IU/mL for equivocal and ≥30 IU/ml for positive antibody detection respectively. 
RESULTS
The study comprised 92 pregnant women, 52 in the second trimester and 40 in the third trimester. The mean age of pregnant women was 24.45±4.4 years (second trimester: 24.4±4.65 years and third trimester: 24.5±4.06 years, p=0.918).The median UIC, mean free T4 and TSH, and median thyroglobulin and anti-TPO antibody were 282.2 μg/L (158.42-376), 1.14±0.41 ng/ dL, 4.57±2.56mIU/L, 6.5 ng/mL (4.0-11.0) and 1.52 IU/ mL (0.97-2.23) respectively. Biochemical parameters in pregnant women in second and third trimester are shown in Table 1 .
Iodine and Thyroid Function Status, and Anti-thyroid Peroxidase Antibody among Pregnant Women 
DISCUSSION
Pregnancy is a condition accompanied by increase in energy and nutrients requirement. Pregnant women require 250 μg intake of iodine per day, and UIC is a good indicator of recent iodine intake. 2, 13 The median UIC among pregnant women in the present study was 282.2 μg/L, which indicates more than adequate iodine intake among pregnant women of eastern Nepal. However, 17 (18.5%) women had UIC<150 μg/L, which indicates insufficient iodine intake in those women recently. There are limited data on iodine status during pregnancy in Nepal, however, in school children there has been continuous improvement in iodine nutrition. 1, [8] [9] [10] [11] In one study, Schulze et al. observed mild iodine deficiency in pregnant and lactating women of rural southern plains (Terai region) of Nepal. 13 In a study in India, median UIC was 203 μg/L and 211 μg/L at 17 and 34 weeks of pregnancy respectively, whereas in another study, median (range) UIC in the first, second, and third trimesters was 285 μg/L (102-457), 318 μg/L (102-805), and 304 μg/L (172-859) respectively.
14,15
We estimated thyroglobulin, the marker for long term iodine nutrition over a period of months or years, for exploring iodine status in Nepalese pregnant women. In the present study, the median thyroglobulin was 6.5 ng/mL, and three women (3.26%) had increased level of thyroglobulin (>40ng/mL). Thyroglobulin level>40ng/mL indicates iodine deficiency in individuals. 16 Our results indicate that most women had sufficient iodine nutrition over a period of time, and only three women had chronic iodine deficiency.Our findings suggest that most pregnant women have sufficient iodine nutrition over a period of time, however, many women seem to have inadequate iodine intake recently. In a study in Sri Lanka, median thyroglobulin was 21.4 IU/L among pregnant women in 39.33 (±1.37) weeks of gestation. 17 In a study done in France,the median thyroglobulin in pregnant women was 16.2 μg/L, and it did not differ across trimesters, and was significantly higher than in the control group of non-pregnant adults (11.7 μg/L) {p=0.02}. 18 Because of the harmful consequences of iodine deficiency on mother and fetus health, it is recommended that pregnant women take extra iodine than normal adults. 17 Universal salt iodization has been the most common strategy of eliminating iodine deficiency in landlocked countries, and this been successful in Nepal with increasing number of households consuming adequately iodized salt and median UIC among school children is rising. 1, 19 Thyroid dysfunction has been observed as the most frequent endocrine disorder in pregnant women. 5 We observed thyroid dysfunction in 19 (20.65%) pregnant women and the most common dysfunction was subclinical hypothyroidism (18, 19 .56%) when the upper normal cutoff value for TSH was taken 6.16 mIU/L. Assay specific reference ranges for thyroid hormones according to pregnancy trimester were unavailable for the kits used in study, so we could not classify the thyroid status accordingly in the present study. The rate of thyroid dysfunction among pregnant women would jump to 68.5% (n=63) if thyroid dysfunction was classified on the basis of trimester specific recommendation for thyroid function by American Thyroid Association which has suggested reference range for TSH if no trimesterspecific reference ranges are available in the laboratory (first trimester, 0.1-2.5 mIU/L; second trimester, 0.2-3.0 mIU/L; third trimester, 0.3-3.0mIU/L). 3 Though, previous findings about thyroid function in Nepalese pregnant women are not available, various studies in metabolic syndrome, diabetes mellitus and kidney disease patients have revealed thyroid dysfunction in large fraction of study patients with subclinical hypothyroidism as the commonest disorder. [20] [21] [22] Recently, a study in school children of eastern Nepal reported thyroid dysfunction in 19.4% of school age children, and 16.3% had subclinical hypothyroidism. 23 When focused with thyroid disorders among pregnant women in other countries, varied rate were reported. Study by Singh et al., found subclinical hypothyroidism and overt hypothyroidism in 18% and 4.5% among pregnant women in first and second trimester respectively. 24 In another study in South West Bengal, subclinical hypothyroidism was reported in 32.94% pregnant women during first trimester. 25 It has been observed that thyroid dysfunction during pregnancy is associated with increased risk of termination of pregnancy and abnormalities in mother and fetus. 6 Autoantibodies against TPO enzyme are predominant fractions of antibodies seen in autoimmune thyroid disorders. 3 In this study, the median anti-TPO was 1.52 IU/mL, and three women (3.26%) had positive anti-TPO antibody, and normal thyroid function was seen in all anti-TPO positive women. The prevalence of autoimmunity toward thyroid protein tends to vary among different ethnic groups and regions. In a study among Indian pregnant women in first trimester, elevated anti-TPO was observed in 27.8% pregnant women. 26 In a study among Spanish pregnant women, anti-TPO level was 0.08 UI/ml, 0.09 UI/ml and 0.09 UI/ml among first, second and third trimester respectively, and 85.22% had normal values for TPO antibody. 27 Our findings suggest that there was mild autoimmunity towards TPO protein in the study population. Although during reproductive age thyroid autoantibodies are found in 5-15% of women, they are not necessarily accompanied by thyroid dysfunction. 28 In the present study too, we did not observe thyroid dysfunction in women with positive anti-TPO. However, many other findings suggest that women with thyroid antibodies have risk of becoming hypothyroid during pregnancy and the presence of thyroid antibodies is a powerful risk marker for transition from subclinical to overt hypothyroidism. 6 We observed adequate iodine nutrition in pregnant women, but high rate of mild thyroid dysfunction. Overt hypothyroidism and overt hyperthyroidism has deleterious effects on pregnancy, and now it has been ascertained about the adverse effects of subclinical hypothyroidism on mother and fetus as well. 4 Thus, screening for thyroid function during pregnancy would be beneficial for better pregnancy outcomes. Our study had some limitations; the sample size was small and anti-TPO positive women were not followed up for future development of thyroid disorder. Thus, future studies are needed with large sample to determine the burden of thyroid dysfunction in Nepalese pregnant women and its subsequent impact on child and mother health.
CONCLUSIONS
The study revealed that most women during pregnancy had sufficient iodine nutrition over period of time; while some women had recent inadequate iodine intake. However, thyroid dysfunction particularly subclinical hypothyroidism seemed to be common, and autoimmunity against TPO enzyme persisted among small portion of Nepalese pregnant women population.
